231 related articles for article (PubMed ID: 36884207)
1. Association between PIRCHE-II scores and de novo allosensitization after reduction of immunosuppression during SARS-CoV-2 infection in kidney transplant recipients.
Castrezana-Lopez K; Malchow R; Nilsson J; Kokkonen SM; Rho E; von Moos S; Mueller TF; Schachtner T
Transpl Infect Dis; 2023 Apr; 25(2):e14052. PubMed ID: 36884207
[TBL] [Abstract][Full Text] [Related]
2. PIRCHE-II scores prove useful as a predictive biomarker among kidney transplant recipients with rejection: An analysis of indication and follow-up biopsies.
Spitznagel T; Matter LS; Kaufmann YL; Nilsson J; von Moos S; Schachtner T
Front Immunol; 2022; 13():949933. PubMed ID: 36059499
[TBL] [Abstract][Full Text] [Related]
3. High PIRCHE Scores May Allow Risk Stratification of Borderline Rejection in Kidney Transplant Recipients.
Lezoeva E; Nilsson J; Wüthrich R; Mueller TF; Schachtner T
Front Immunol; 2022; 13():788818. PubMed ID: 35250973
[TBL] [Abstract][Full Text] [Related]
4. Analysis of T and B Cell Epitopes to Predict the Risk of
Sakamoto S; Iwasaki K; Tomosugi T; Niemann M; Spierings E; Miwa Y; Horimi K; Takeda A; Goto N; Narumi S; Watarai Y; Kobayashi T
Front Immunol; 2020; 11():2000. PubMed ID: 32973806
[TBL] [Abstract][Full Text] [Related]
5. Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation.
Lachmann N; Niemann M; Reinke P; Budde K; Schmidt D; Halleck F; Pruß A; Schönemann C; Spierings E; Staeck O
Am J Transplant; 2017 Dec; 17(12):3076-3086. PubMed ID: 28613392
[TBL] [Abstract][Full Text] [Related]
6. Exploring predicted indirectly recognizable HLA epitopes (PIRCHE-II) in liver transplant recipients on calcineurin inhibitor-free maintenance immunosuppression. A retrospective single center study.
Meszaros M; Niemann M; Ursic-Bedoya J; Faure S; Meunier L; Rivière B; Costes-Martineau V; Thevenin C; Pageaux GP
Transpl Immunol; 2020 Apr; 59():101272. PubMed ID: 32061667
[TBL] [Abstract][Full Text] [Related]
7. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
[TBL] [Abstract][Full Text] [Related]
8. Immunologic risk stratification of pediatric heart transplant patients by combining HLAMatchmaker and PIRCHE-II.
Mangiola M; Ellison MA; Marrari M; Bentlejewski C; Sadowski J; Zern D; Niemann M; Feingold B; Webber SA; Zeevi A;
J Heart Lung Transplant; 2022 Jul; 41(7):952-960. PubMed ID: 35437211
[TBL] [Abstract][Full Text] [Related]
9. Association of HLA B- and T-cell molecular mismatches with HLA antibodies, rejection, and graft survival in pediatric kidney transplantation.
Gramkow AM; Baatrup JH; Gramkow ET; Thiesson HC; Koefoed-Nielsen P
Pediatr Transplant; 2024 Aug; 28(5):e14773. PubMed ID: 38808702
[TBL] [Abstract][Full Text] [Related]
10. Eplet Mismatch Load and
Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
[TBL] [Abstract][Full Text] [Related]
11. PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.
Geneugelijk K; Niemann M; Drylewicz J; van Zuilen AD; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Hack CE; van Reekum FE; Verhaar MC; Kamburova EG; Bots ML; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MGJ; Vanderlocht J; Voorter CE; Wieten L; van Duijnhoven EM; Gelens M; Christiaans MHL; van Ittersum FJ; Nurmohamed A; Lardy JNM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG; Spierings E
Front Immunol; 2018; 9():321. PubMed ID: 29556227
[TBL] [Abstract][Full Text] [Related]
12. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation.
Otten HG; Calis JJ; Keşmir C; van Zuilen AD; Spierings E
Hum Immunol; 2013 Mar; 74(3):290-6. PubMed ID: 23232063
[TBL] [Abstract][Full Text] [Related]
13. [Relationship of distribution frequency of HLA antigen/antibody and PIRCHE score with DSA production and AMR occurrence].
Zheng J; Kuang PD; Zhang Y; Zhao Q; He XL; Ding XM; Xue WJ
Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(12):901-906. PubMed ID: 30917438
[No Abstract] [Full Text] [Related]
14. Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II.
Ellison M; Mangiola M; Marrari M; Bentlejewski C; Sadowski J; Zern D; Kramer CSM; Heidt S; Niemann M; Xu Q; Dipchand AI; Mahle WT; Rossano JW; Canter CE; Singh TP; Zuckerman WA; Hsu DT; Feingold B; Webber SA; Zeevi A
Front Immunol; 2023; 14():1110292. PubMed ID: 36999035
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulins do not prove beneficial to reduce alloimmunity among kidney transplant recipients with BKV-associated nephropathy.
Naef B; Nilsson J; Wuethrich RP; Mueller TF; Schachtner T
Transpl Int; 2021 Aug; 34(8):1481-1493. PubMed ID: 33872427
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and Clinical Significance of De Novo Donor-Specific Anti-HLA Antibodies after Kidney Transplantation.
Jung HY; Kim SH; Seo MY; Cho SY; Yang Y; Choi JY; Cho JH; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
J Korean Med Sci; 2018 Aug; 33(34):e217. PubMed ID: 30127706
[TBL] [Abstract][Full Text] [Related]
17. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
[TBL] [Abstract][Full Text] [Related]
18. Can PIRCHE-II Matching Outmatch Traditional HLA Matching?
Unterrainer C; Döhler B; Niemann M; Lachmann N; Süsal C
Front Immunol; 2021; 12():631246. PubMed ID: 33717167
[TBL] [Abstract][Full Text] [Related]
19. Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.
Snanoudj R; Kamar N; Cassuto E; Caillard S; Metzger M; Merville P; Thierry A; Jollet I; Grimbert P; Anglicheau D; Hazzan M; Choukroun G; Hurault De Ligny B; Janbon B; Vuiblet V; Devys A; Le Meur Y; Delahousse M; Morelon E; Bailly E; Girerd S; Amokrane K; Legendre C; Hertig A; Rondeau E; Taupin JL
Kidney Int; 2019 Jun; 95(6):1471-1485. PubMed ID: 30955869
[TBL] [Abstract][Full Text] [Related]
20. Human leukocyte antigen epitope mismatch loads and the development of de novo donor-specific antibodies in cardiothoracic organ transplantation.
Bedford A; Jervis S; Worthington J; Lowe M; Poulton K
Int J Immunogenet; 2022 Feb; 49(1):30-38. PubMed ID: 34904369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
